Sirolimus

CAS 53123-88-9C51H79NO13MW 914.2

Sirolimus（CAS 53123-88-9）：分子式 C51H79NO13、分子量 914.2；类别有机化学品。

规格参数

CAS号53123-88-9

分子式C51H79NO13

分子量914.2

熔点183-185 °C

沸点183-185

LogP4.63

应用领域Uses: Triene macrolide antibiotic derived from Streptomyces hygroscopicus、Used in immunochemistry research and as a therapeutic immunosuppressant and antirestenotic (blocks reoccurrence of stenosis)、[Merck Index]、Tool for immunochemistry.、Medication: Immunosuppressant、Used to prevent rejection in organ transplantation、it is especially useful in kidney transplants. [Wikipedia]、Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients、Methods of Manufacturing: Triene macrolide antibiotic isolated from Streptomyces hygroscopicus.、Formulations、Preparations: Rapamune、Rapamycin、Oral: Solution 1mg、mL Rapamune (Wyeth). Tablets: 1 mg Rapamune (with povidone)、(Wyeth)、2 mg Rapamune (with Povidone)、(Wyeth).、General Manufacturing Information: Information available in 2004 indicated that Sirolimus was used in the manufacture of pharmaceutical preparations in the following countries: Argentina、Australia、Austria、Belgium、Brazil、Canada、Chile、Colombia、Czech Republic、Denmark、Finland、France、Germany、Greece、Ireland、Israel、Italy、Mexico、New Zealand、Norway、Poland、Romania、Singapore、Spain、Sweden、Switzerland、Thailand、United Kingdom、USA (1、2)

类别Organic Chemicals

用途与场景

登记用途：Uses: Triene macrolide antibiotic derived from Streptomyces hygroscopicus、Used in immunochemistry research and as a therapeutic immunosuppressant and antirestenotic (blocks reoccurrence of stenosis)、[Merck Index]、Tool for immunochemistry.、Medication: Immunosuppressant、Used to prevent rejection in organ transplantation、it is especially useful in kidney transplants. [Wikipedia]、Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients、Methods of Manufacturing: Triene macrolide antibiotic isolated from Streptomyces hygroscopicus.、Formulations、Preparations: Rapamune、Rapamycin、Oral: Solution 1mg、mL Rapamune (Wyeth). Tablets: 1 mg Rapamune (with povidone)、(Wyeth)、2 mg Rapamune (with Povidone)、(Wyeth).、General Manufacturing Information: Information available in 2004 indicated that Sirolimus was used in the manufacture of pharmaceutical preparations in the following countries: Argentina、Australia、Austria、Belgium、Brazil、Canada、Chile、Colombia、Czech Republic、Denmark、Finland、France、Germany、Greece、Ireland、Israel、Italy、Mexico、New Zealand、Norway、Poland、Romania、Singapore、Spain、Sweden、Switzerland、Thailand、United Kingdom、USA (1、2)。

采购档案

这个产品是什么

Sirolimus 是一种以碳骨架为基础的有机化合物，登记 CAS 号为 53123-88-9，分子式 C51H79NO13（分子量 914.2），归属于有机化学品大类化工原料。

识别信息

登记 CAS 号：53123-88-9

其分子式 C51H79NO13 由 51 个碳、79 个氢、1 个氮、13 个氧组成。

别名/同义词：Sirolimus · Rapamycin

所属分类：有机化学品

常见问题

Sirolimus 的 CAS 号是多少？

Sirolimus 的 CAS 登记号为 53123-88-9。

Sirolimus 的分子式与分子量是多少？

分子式 C51H79NO13，分子量 914.2。

Sirolimus 还有哪些别名？

别名/同义词：Sirolimus、Rapamycin。

Sirolimus 的登记用途是什么？

登记用途：Uses: Triene macrolide antibiotic derived from Streptomyces hygroscopicus、Used in immunochemistry research and as a therapeutic immunosuppressant and antirestenotic (blocks reoccurrence of stenosis)、[Merck Index]、Tool for immunochemistry.、Medication: Immunosuppressant、Used to prevent rejection in organ transplantation、it is especially useful in kidney transplants. [Wikipedia]、Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients、Methods of Manufacturing: Triene macrolide antibiotic isolated from Streptomyces hygroscopicus.、Formulations、Preparations: Rapamune、Rapamycin、Oral: Solution 1mg、mL Rapamune (Wyeth). Tablets: 1 mg Rapamune (with povidone)、(Wyeth)、2 mg Rapamune (with Povidone)、(Wyeth).、General Manufacturing Information: Information available in 2004 indicated that Sirolimus was used in the manufacture of pharmaceutical preparations in the following countries: Argentina、Australia、Austria、Belgium、Brazil、Canada、Chile、Colombia、Czech Republic、Denmark、Finland、France、Germany、Greece、Ireland、Israel、Italy、Mexico、New Zealand、Norway、Poland、Romania、Singapore、Spain、Sweden、Switzerland、Thailand、United Kingdom、USA (1、2)。

Sirolimus 属于哪个分类？

所属分类：Organic Chemicals。

PubChem 公开数据

Sirolimus（CAS 53123-88-9）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

GHS notification summary	4.7% (2 / 43)
Reported hazard statements	H341 (11.6%), H351 (79.1%), H361 (81.4%), H372 (81.4%)

This chemical does not meet GHS hazard criteria for 4.7% (2 of 43) of reports.

H341 (11.6%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]

法规与备案状态

GHS notification summary	4.7% (2 / 43)

物理形态与操作说明

Colorless solid; [Merck Index]
Solid
Colorless crystalline solid from ether
Sol in ether, chloroform, acetone, methanol, and DMF; very sparingly sol in hexane and petr ether.
In water = 9.9X10-5 mg/L at 25 °C /Estimated/
log Kow = 4.81 /Estimated/

公开数据库收录的理化数据

沸点	183-185
熔点	183-185 °C
溶解度	1.73e-03 g/L
LogP	4.63
LogP	4.3

这个物质在各数据库里的编号

CAS Registry Number	53123-88-9
PubChem CID	5284616
分子式	C51H79NO13
IUPAC 名称	(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
UNII（FDA）	W36ZG6FT64

数据库记载的用途

Triene macrolide antibiotic derived from Streptomyces hygroscopicus; Used in immunochemistry research and as a therapeutic immunosuppressant and antirestenotic (blocks reoccurrence of stenosis); [Merck Index]
Used to prevent rejection in organ transplantation; it is especially useful in kidney transplants. [Wikipedia]
Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
Triene macrolide antibiotic isolated from Streptomyces hygroscopicus.
Information available in 2004 indicated that Sirolimus was used in the manufacture of pharmaceutical preparations in the following countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Mexico, New Zealand, Norway, Poland, Romania, Singapore, Spain, Sweden, Switzerland, Thailand, United Kingdom, USA (1,2)
Sirolimus is macrocyclic antibiotic with potent immunosuppressive activity that is used alone or in combination with calcineurin inhibitors and corticosteroids to prevent cellular rejection after renal transplantation. Sirolimus therapy can be associated with mild serum enzyme elevations and it has been linked to rare instances of clinically apparent cholestatic liver injury.

它在各数据库里的别名

rapamycin; Sirolimus; (-)-Rapamycin; 53123-88-9; Rapamune; rapalimus; AY-22989; WY-090217; FYARRO; HYFTOR; sirolimusum; Npc-12g; Antibiotic AY 22989; RAPA; Rapammune; SILA 9268A

计算机算出的分子描述符

分子量	914.2
XLogP3	6
氢键供体数	3
氢键受体数	13
可旋转键数	6
精确质量	913.55514157
单同位素质量	913.55514157
拓扑极性表面积	195
重原子数	65
形式电荷	0

数据库摘要

Sirolimus · CAS 53123-88-9 · C51H79NO13. UNII W36ZG6FT64. 沸点: 183-185; 熔点: 183-185 °C; 溶解度: 1.73e-03 g/L.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。